Risk of emergency hospital admission related to adverse events after antibiotic treatment in adults with a common infection: impact of COVID-19 and derivation and validation of risk prediction models
Background: With the global challenge of antimicrobial resistance intensified during the COVID-19 pandemic, evaluating adverse events (AEs) post-antibiotic treatment for common infections is crucial. This study aims to examines the changes in incidence rates of AEs during the COVID-19 pandemic and p...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2024
|
_version_ | 1811139930538115072 |
---|---|
author | Zhong, X Palin, V Ashcroft, DM Goldacre, B MacKenna, B Mehrkar, A Bacon, SCJ Massey, J Inglesby, P Hand, K Pate, A van Staa, TP |
author_facet | Zhong, X Palin, V Ashcroft, DM Goldacre, B MacKenna, B Mehrkar, A Bacon, SCJ Massey, J Inglesby, P Hand, K Pate, A van Staa, TP |
author_sort | Zhong, X |
collection | OXFORD |
description | Background: With the global challenge of antimicrobial resistance intensified during the COVID-19 pandemic, evaluating adverse events (AEs) post-antibiotic treatment for common infections is crucial. This study aims to examines the changes in incidence rates of AEs during the COVID-19 pandemic and predict AE risk following antibiotic prescriptions for common infections, considering their previous antibiotic exposure and other long-term clinical conditions. Methods: With the approval of NHS England, we used OpenSAFELY platform and analysed electronic health records from patients aged 18–110, prescribed antibiotics for urinary tract infection (UTI), lower respiratory tract infections (LRTI), upper respiratory tract infections (URTI), sinusitis, otitis externa, and otitis media between January 2019 and June 2023. We evaluated the temporal trends in the incidence rate of AEs for each infection, analysing monthly changes over time. The survival probability of emergency AE hospitalisation was estimated in each COVID-19 period (period 1: 1 January 2019 to 25 March 2020, period 2: 26 March 2020 to 8 March 2021, period 3: 9 March 2021 to 30 June 2023) using the Kaplan–Meier approach. Prognostic models, using Cox proportional hazards regression, were developed and validated to predict AE risk within 30 days post-prescription using the records in Period 1. Results: Out of 9.4 million patients who received antibiotics, 0.6% of UTI, 0.3% of URTI, and 0.5% of LRTI patients experienced AEs. UTI and LRTI patients demonstrated a higher risk of AEs, with a noted increase in AE incidence during the COVID-19 pandemic. Higher comorbidity and recent antibiotic use emerged as significant AE predictors. The developed models exhibited good calibration and discrimination, especially for UTIs and LRTIs, with a C-statistic above 0.70. Conclusions: The study reveals a variable incidence of AEs post-antibiotic treatment for common infections, with UTI and LRTI patients facing higher risks. AE risks varied between infections and COVID-19 periods. These findings underscore the necessity for cautious antibiotic prescribing and call for further exploration into the intricate dynamics between antibiotic use, AEs, and the pandemic. |
first_indexed | 2024-09-25T04:13:55Z |
format | Journal article |
id | oxford-uuid:6f796e73-e3d4-4c05-9d55-d470c4ec479b |
institution | University of Oxford |
language | English |
last_indexed | 2024-09-25T04:13:55Z |
publishDate | 2024 |
publisher | BioMed Central |
record_format | dspace |
spelling | oxford-uuid:6f796e73-e3d4-4c05-9d55-d470c4ec479b2024-07-13T20:05:23ZRisk of emergency hospital admission related to adverse events after antibiotic treatment in adults with a common infection: impact of COVID-19 and derivation and validation of risk prediction modelsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6f796e73-e3d4-4c05-9d55-d470c4ec479bEnglishJisc Publications RouterBioMed Central2024Zhong, XPalin, VAshcroft, DMGoldacre, BMacKenna, BMehrkar, ABacon, SCJMassey, JInglesby, PHand, KPate, Avan Staa, TPBackground: With the global challenge of antimicrobial resistance intensified during the COVID-19 pandemic, evaluating adverse events (AEs) post-antibiotic treatment for common infections is crucial. This study aims to examines the changes in incidence rates of AEs during the COVID-19 pandemic and predict AE risk following antibiotic prescriptions for common infections, considering their previous antibiotic exposure and other long-term clinical conditions. Methods: With the approval of NHS England, we used OpenSAFELY platform and analysed electronic health records from patients aged 18–110, prescribed antibiotics for urinary tract infection (UTI), lower respiratory tract infections (LRTI), upper respiratory tract infections (URTI), sinusitis, otitis externa, and otitis media between January 2019 and June 2023. We evaluated the temporal trends in the incidence rate of AEs for each infection, analysing monthly changes over time. The survival probability of emergency AE hospitalisation was estimated in each COVID-19 period (period 1: 1 January 2019 to 25 March 2020, period 2: 26 March 2020 to 8 March 2021, period 3: 9 March 2021 to 30 June 2023) using the Kaplan–Meier approach. Prognostic models, using Cox proportional hazards regression, were developed and validated to predict AE risk within 30 days post-prescription using the records in Period 1. Results: Out of 9.4 million patients who received antibiotics, 0.6% of UTI, 0.3% of URTI, and 0.5% of LRTI patients experienced AEs. UTI and LRTI patients demonstrated a higher risk of AEs, with a noted increase in AE incidence during the COVID-19 pandemic. Higher comorbidity and recent antibiotic use emerged as significant AE predictors. The developed models exhibited good calibration and discrimination, especially for UTIs and LRTIs, with a C-statistic above 0.70. Conclusions: The study reveals a variable incidence of AEs post-antibiotic treatment for common infections, with UTI and LRTI patients facing higher risks. AE risks varied between infections and COVID-19 periods. These findings underscore the necessity for cautious antibiotic prescribing and call for further exploration into the intricate dynamics between antibiotic use, AEs, and the pandemic. |
spellingShingle | Zhong, X Palin, V Ashcroft, DM Goldacre, B MacKenna, B Mehrkar, A Bacon, SCJ Massey, J Inglesby, P Hand, K Pate, A van Staa, TP Risk of emergency hospital admission related to adverse events after antibiotic treatment in adults with a common infection: impact of COVID-19 and derivation and validation of risk prediction models |
title | Risk of emergency hospital admission related to adverse events after antibiotic treatment in adults with a common infection: impact of COVID-19 and derivation and validation of risk prediction models |
title_full | Risk of emergency hospital admission related to adverse events after antibiotic treatment in adults with a common infection: impact of COVID-19 and derivation and validation of risk prediction models |
title_fullStr | Risk of emergency hospital admission related to adverse events after antibiotic treatment in adults with a common infection: impact of COVID-19 and derivation and validation of risk prediction models |
title_full_unstemmed | Risk of emergency hospital admission related to adverse events after antibiotic treatment in adults with a common infection: impact of COVID-19 and derivation and validation of risk prediction models |
title_short | Risk of emergency hospital admission related to adverse events after antibiotic treatment in adults with a common infection: impact of COVID-19 and derivation and validation of risk prediction models |
title_sort | risk of emergency hospital admission related to adverse events after antibiotic treatment in adults with a common infection impact of covid 19 and derivation and validation of risk prediction models |
work_keys_str_mv | AT zhongx riskofemergencyhospitaladmissionrelatedtoadverseeventsafterantibiotictreatmentinadultswithacommoninfectionimpactofcovid19andderivationandvalidationofriskpredictionmodels AT palinv riskofemergencyhospitaladmissionrelatedtoadverseeventsafterantibiotictreatmentinadultswithacommoninfectionimpactofcovid19andderivationandvalidationofriskpredictionmodels AT ashcroftdm riskofemergencyhospitaladmissionrelatedtoadverseeventsafterantibiotictreatmentinadultswithacommoninfectionimpactofcovid19andderivationandvalidationofriskpredictionmodels AT goldacreb riskofemergencyhospitaladmissionrelatedtoadverseeventsafterantibiotictreatmentinadultswithacommoninfectionimpactofcovid19andderivationandvalidationofriskpredictionmodels AT mackennab riskofemergencyhospitaladmissionrelatedtoadverseeventsafterantibiotictreatmentinadultswithacommoninfectionimpactofcovid19andderivationandvalidationofriskpredictionmodels AT mehrkara riskofemergencyhospitaladmissionrelatedtoadverseeventsafterantibiotictreatmentinadultswithacommoninfectionimpactofcovid19andderivationandvalidationofriskpredictionmodels AT baconscj riskofemergencyhospitaladmissionrelatedtoadverseeventsafterantibiotictreatmentinadultswithacommoninfectionimpactofcovid19andderivationandvalidationofriskpredictionmodels AT masseyj riskofemergencyhospitaladmissionrelatedtoadverseeventsafterantibiotictreatmentinadultswithacommoninfectionimpactofcovid19andderivationandvalidationofriskpredictionmodels AT inglesbyp riskofemergencyhospitaladmissionrelatedtoadverseeventsafterantibiotictreatmentinadultswithacommoninfectionimpactofcovid19andderivationandvalidationofriskpredictionmodels AT handk riskofemergencyhospitaladmissionrelatedtoadverseeventsafterantibiotictreatmentinadultswithacommoninfectionimpactofcovid19andderivationandvalidationofriskpredictionmodels AT patea riskofemergencyhospitaladmissionrelatedtoadverseeventsafterantibiotictreatmentinadultswithacommoninfectionimpactofcovid19andderivationandvalidationofriskpredictionmodels AT vanstaatp riskofemergencyhospitaladmissionrelatedtoadverseeventsafterantibiotictreatmentinadultswithacommoninfectionimpactofcovid19andderivationandvalidationofriskpredictionmodels |